These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 24055690)

  • 1. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.
    Tewes F; Ehrhardt C; Healy AM
    Eur J Pharm Biopharm; 2014 Jan; 86(1):98-104. PubMed ID: 24055690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.
    Stocke NA; Meenach SA; Arnold SM; Mansour HM; Hilt JZ
    Int J Pharm; 2015 Feb; 479(2):320-8. PubMed ID: 25542988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Characterization of Magnetic Nano-in-Microparticles for Pulmonary Delivery.
    McBride AA; Price DN; Muttil P
    Methods Mol Biol; 2017; 1530():99-108. PubMed ID: 28150197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.
    Amaro MI; Tajber L; Corrigan OI; Healy AM
    Pharm Res; 2015 Jan; 32(1):180-95. PubMed ID: 25074469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of novel magnetic nano-in-microparticles for site-specific pulmonary drug delivery.
    McBride AA; Price DN; Lamoureux LR; Elmaoued AA; Vargas JM; Adolphi NL; Muttil P
    Mol Pharm; 2013 Oct; 10(10):3574-81. PubMed ID: 23964796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Pulmonary Delivery and Magnetic-Targeting of Dry Powder Nano-in-Microparticles.
    Price DN; Stromberg LR; Kunda NK; Muttil P
    Mol Pharm; 2017 Dec; 14(12):4741-4750. PubMed ID: 29068693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.
    Abbas Y; Azzazy HM; Tammam S; Lamprecht A; Ali ME; Schmidt A; Sollazzo S; Mathur S
    Colloids Surf B Biointerfaces; 2016 Oct; 146():19-30. PubMed ID: 27244047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
    Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release microparticle dry powders of chloramphenicol palmitate or thiamphenicol palmitate prodrugs for lung delivery as aerosols.
    Nurbaeti SN; Brillault J; Tewes F; Olivier JC
    Eur J Pharm Sci; 2019 Oct; 138():105028. PubMed ID: 31377132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of different vitamin E carriers intended for pulmonary drug delivery.
    Laouini A; Andrieu V; Vecellio L; Fessi H; Charcosset C
    Int J Pharm; 2014 Aug; 471(1-2):385-90. PubMed ID: 24939617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting intracellular compartments by magnetic polymeric nanoparticles.
    Kocbek P; Kralj S; Kreft ME; Kristl J
    Eur J Pharm Sci; 2013 Sep; 50(1):130-8. PubMed ID: 23603023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery.
    Gomez AI; Acosta MF; Muralidharan P; Yuan JX; Black SM; Hayes D; Mansour HM
    Pulm Pharmacol Ther; 2020 Oct; 64():101975. PubMed ID: 33137515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of magnetic aerosol droplets to the lung.
    Dames P; Gleich B; Flemmer A; Hajek K; Seidl N; Wiekhorst F; Eberbeck D; Bittmann I; Bergemann C; Weyh T; Trahms L; Rosenecker J; Rudolph C
    Nat Nanotechnol; 2007 Aug; 2(8):495-9. PubMed ID: 18654347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ciprofloxacin-loaded poly(vinyl alcohol) dry powder formulations for lung delivery.
    Silva DM; Paleco R; Traini D; Sencadas V
    Int J Pharm; 2018 Aug; 547(1-2):114-121. PubMed ID: 29803795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
    Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H
    Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.